Comparison of Traditional Dysphagia Therapy and Developed Protocol for Dysphagia Patients in Intensive Care Unit

NCT ID: NCT07005427

Last Updated: 2025-08-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-02

Study Completion Date

2026-05-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dysphagia (swallowing disorders) in intensive care unit (ICU) patients is associated with poor outcomes, including aspiration pneumonia, prolonged hospitalization, and increased mortality. Traditional dysphagia management approaches may be insufficient for the unique needs of critically ill patients. This study aims to evaluate the effectiveness of a newly developed ICU-specific dysphagia protocol compared to traditional therapy approaches.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study are:

1. To compare the efficacy of traditional dysphagia therapy versus a developed ICU-specific protocol in improving swallowing function
2. To assess the impact of both approaches on clinical outcomes including aspiration rates, time to oral intake, ICU length of stay, and pneumonia incidence
3. To identify patient subgroups that may benefit most from the specialized protocol Methods Study Design

* Prospective randomized controlled trial
* Single-center study in a tertiary hospital ICU
* 1:1 randomization to intervention or control group Participants
* Total sample size: 90 adult ICU patients (45 per group)
* Inclusion criteria: Adult patients (≥18 years) admitted to ICU with confirmed dysphagia by bedside evaluation within 72 hours of admission
* Exclusion criteria: Preexisting neurological disorders affecting swallowing, head and neck cancer, inability to follow commands, expected ICU stay \<48 hours This study will provide evidence for the efficacy of a specialized dysphagia management protocol tailored to the unique needs of critically ill patients. If proven effective, the protocol could establish new standards of care for dysphagia management in ICU settings, potentially improving patient outcomes and reducing healthcare costs associated with dysphagia-related complications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dysphagia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comparison group

This Group will receive traditional dysphagia therapy.

Group Type ACTIVE_COMPARATOR

dysphagia therapy

Intervention Type OTHER

This group will receive usual dysphagia care as provided in ICU settings

* Standard bedside swallowing evaluation
* Conventional compensatory strategies (postural changes, diet modifications)
* Traditional exercises focusing on oral motor control
* Therapy sessions 3 times per week for 30 minutes

Experimental Group

This group will receive treatment as per recently designed dysphagia management protocol, that includes the role of early mobilization, dietary intervention with varying postures, and overall care designed for first 48 hours.

Group Type EXPERIMENTAL

Designed protocol for dysphagia

Intervention Type BEHAVIORAL

* Innovative strengthening exercises adapted for ICU setting
* Early mobilization component
* ICU-specific compensatory strategies
* Therapy sessions 5 times per week for 30 minutes with additional brief daily reinforcement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dysphagia therapy

This group will receive usual dysphagia care as provided in ICU settings

* Standard bedside swallowing evaluation
* Conventional compensatory strategies (postural changes, diet modifications)
* Traditional exercises focusing on oral motor control
* Therapy sessions 3 times per week for 30 minutes

Intervention Type OTHER

Designed protocol for dysphagia

* Innovative strengthening exercises adapted for ICU setting
* Early mobilization component
* ICU-specific compensatory strategies
* Therapy sessions 5 times per week for 30 minutes with additional brief daily reinforcement

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

traditional dysphagia therapy Guidelines

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (≥18 years) admitted to ICU with confirmed dysphagia by bedside evaluation within 72 hours of admission
* GCS more then 8

Exclusion Criteria

* Preexisting neurological disorders affecting swallowing, head and neck cancer, inability to follow commands, expected ICU stay \<48 hours
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anum Ashraf, PhD*

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Nazia Mumtaz, PhD*

Role: STUDY_DIRECTOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Riphah International University Lahore Campus

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Anum Ashraf REC/RCR & AHS/22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prevention of Refeeding Syndrome
NCT06589479 NOT_YET_RECRUITING